121 related articles for article (PubMed ID: 35351630)
21. A phase I/II trial of chemoembolization for hepatocellular carcinoma using a novel intra-arterial drug-eluting bead.
Poon RT; Tso WK; Pang RW; Ng KK; Woo R; Tai KS; Fan ST
Clin Gastroenterol Hepatol; 2007 Sep; 5(9):1100-8. PubMed ID: 17627902
[TBL] [Abstract][Full Text] [Related]
22. Safety and Feasibility of Chemoembolization with Doxorubicin-Loaded Small Calibrated Microspheres in Patients with Hepatocellular Carcinoma: Results of the MIRACLE I Prospective Multicenter Study.
Richter G; Radeleff B; Stroszczynski C; Pereira P; Helmberger T; Barakat M; Huppert P
Cardiovasc Intervent Radiol; 2018 Apr; 41(4):587-593. PubMed ID: 29167967
[TBL] [Abstract][Full Text] [Related]
23. Five-Years Outcome Analysis of 142 Consecutive Hepatocellular Carcinoma Patients Treated with Doxorubicin Eluting Microspheres 30-60 μm: Results from a Single-Centre Prospective Phase II Trial.
Malagari K; Moschouris H; Kiakidis T; Harward S; Kelekis A; Vrakas S; Koundouras D; Filipiadis D; Glantzounis G; Emmanouil E; Chatziioannou A; Vergadis V; Elefsiniotis I; Koskinas J; Dourakis S; Kelekis N
Cardiovasc Intervent Radiol; 2019 Nov; 42(11):1551-1562. PubMed ID: 31321482
[TBL] [Abstract][Full Text] [Related]
24. Safety and efficacy of doxorubicin drug-eluting bead transarterial chemoembolization in patients with advanced hepatocellular carcinoma.
Prajapati HJ; Dhanasekaran R; El-Rayes BF; Kauh JS; Maithel SK; Chen Z; Kim HS
J Vasc Interv Radiol; 2013 Mar; 24(3):307-15. PubMed ID: 23375519
[TBL] [Abstract][Full Text] [Related]
25. Effectiveness and safety of doxorubicin loaded beads in hepatocellular carcinoma.
Muros-Ortega M; Díaz-Carrasco MS; Capel A; Calleja MÁ; Martínez F
Int J Clin Pharm; 2013 Dec; 35(6):1105-12. PubMed ID: 23928684
[TBL] [Abstract][Full Text] [Related]
26. Degradable starch microspheres transarterial chemoembolization (DSMs-TACE) in patients with unresectable hepatocellular carcinoma (HCC): long-term results from a single-center 137-patient cohort prospective study.
Orlacchio A; Chegai F; Roma S; Merolla S; Bosa A; Francioso S
Radiol Med; 2020 Jan; 125(1):98-106. PubMed ID: 31583558
[TBL] [Abstract][Full Text] [Related]
27. DEB TACE for Intermediate and advanced HCC - Initial Experience in a Brazilian Cancer Center.
Luz JH; Luz PM; Martin HS; Gouveia HR; Levigard RB; Nogueira FD; Rodrigues BC; de Miranda TN; Mamede MH
Cancer Imaging; 2017 Feb; 17(1):5. PubMed ID: 28166821
[TBL] [Abstract][Full Text] [Related]
28. Conventional versus doxorubicin-eluting bead transarterial chemoembolization for hepatocellular carcinoma.
Sacco R; Bargellini I; Bertini M; Bozzi E; Romano A; Petruzzi P; Tumino E; Ginanni B; Federici G; Cioni R; Metrangolo S; Bertoni M; Bresci G; Parisi G; Altomare E; Capria A; Bartolozzi C
J Vasc Interv Radiol; 2011 Nov; 22(11):1545-52. PubMed ID: 21849247
[TBL] [Abstract][Full Text] [Related]
29. Transarterial chemoembolization with medium-sized doxorubicin-eluting Callisphere is safe and effective for patients with hepatocellular carcinoma.
Wang CY; Xia JG; Yang ZQ; Zhou WZ; Chen WH; Qi CJ; Gu JP; Wang Q
Sci Rep; 2020 Mar; 10(1):4434. PubMed ID: 32157110
[TBL] [Abstract][Full Text] [Related]
30. Multicentre prospective study of drug-eluting bead chemoembolisation safety using tightly calibrated small microspheres in non-resectable hepatocellular carcinoma.
Urbano J; Echevarria-Uraga JJ; Ciampi-Dopazo JJ; Sánchez-Corral JA; Cobos Alonso J; Anton-Ladislao A; Peña-Baranda B; Nacarino-Mejias V; González-Costero R; Muñoz Ruiz-Canela JJ; Pérez-Cuesta J; Lanciego C; de Gregorio MA
Eur J Radiol; 2020 May; 126():108966. PubMed ID: 32278280
[TBL] [Abstract][Full Text] [Related]
31. Hepatic arterial infusion of doxorubicin-loaded microsphere for treatment of hepatocellular cancer: a multi-institutional registry.
Martin RC; Rustein L; Pérez Enguix D; Palmero J; Carvalheiro V; Urbano J; Valdata A; Kralj I; Bosnjakovic P; Tatum C
J Am Coll Surg; 2011 Oct; 213(4):493-500. PubMed ID: 21856182
[TBL] [Abstract][Full Text] [Related]
32. Safety and feasibility of same-day discharge of patients with unresectable hepatocellular carcinoma treated with doxorubicin drug-eluting bead transcatheter chemoembolization.
Prajapati HJ; Rafi S; El-Rayes BF; Kauh JS; Kooby DA; Kim HS
J Vasc Interv Radiol; 2012 Oct; 23(10):1286-93.e1. PubMed ID: 22999748
[TBL] [Abstract][Full Text] [Related]
33. Radiopaque beads loaded with doxorubicin in the treatment of patients with hepatocellular carcinoma: A retrospective, multi-center study.
Lakhoo J; Adams R; Dave A; Luo L; Vargo CJ; Isaacson AJ; Sher A; Fischman A; Yee DC; Ryan S; Patel S; Duchac D; Brown DB
Cancer Treat Res Commun; 2020; 25():100208. PubMed ID: 32932173
[TBL] [Abstract][Full Text] [Related]
34. Transarterial Chemoembolization with Small Drug-Eluting Beads in Patients with Hepatocellular Carcinoma: Experience from a Cohort of 421 Patients at an Italian Center.
Aliberti C; Carandina R; Lonardi S; Dadduzio V; Vitale A; Gringeri E; Zanus G; Cillo U
J Vasc Interv Radiol; 2017 Nov; 28(11):1495-1502. PubMed ID: 28927662
[TBL] [Abstract][Full Text] [Related]
35. Transarterial chemoembolization for hepatocellular carcinoma with a new generation of beads: clinical-radiological outcomes and safety profile.
Spreafico C; Cascella T; Facciorusso A; Sposito C; Rodolfo L; Morosi C; Civelli EM; Vaiani M; Bhoori S; Pellegrinelli A; Marchianò A; Mazzaferro V
Cardiovasc Intervent Radiol; 2015 Feb; 38(1):129-34. PubMed ID: 24870698
[TBL] [Abstract][Full Text] [Related]
36. Short-term efficacy and safety of callispheres drug-loaded microsphere embolization in primary hepatocellular carcinoma.
Li J; Wang N; Shi C; Liu Q; Song J; Ye X
J Cancer Res Ther; 2021 Jul; 17(3):733-739. PubMed ID: 34269307
[TBL] [Abstract][Full Text] [Related]
37. Drug-Eluting Microsphere Versus Cisplatin-Based Transarterial Chemoembolization for the Treatment of Hepatocellular Carcinoma: Propensity Score-Matched Analysis.
Chu HH; Gwon DI; Kim JH; Ko GY; Shin JH; Yoon HK
AJR Am J Roentgenol; 2020 Sep; 215(3):745-752. PubMed ID: 32569514
[No Abstract] [Full Text] [Related]
38. Transarterial chemoembolization of unresectable hepatocellular carcinoma with drug eluting beads: results of an open-label study of 62 patients.
Malagari K; Chatzimichael K; Alexopoulou E; Kelekis A; Hall B; Dourakis S; Delis S; Gouliamos A; Kelekis D
Cardiovasc Intervent Radiol; 2008; 31(2):269-80. PubMed ID: 17999110
[TBL] [Abstract][Full Text] [Related]
39. Super-selective transarterial chemoembolization of hepatocellular carcinoma with doxorubicin-eluting beads sized 40-75 microns: assessment of efficacy and safety.
Ballı HT; Aikimbaev K
Diagn Interv Radiol; 2020 Sep; 26(5):482-487. PubMed ID: 32815520
[TBL] [Abstract][Full Text] [Related]
40. Factors affecting survival following chemoembolization with doxorubicin-eluting microspheres for inoperable hepatocellular carcinoma.
Kalva SP; Pectasides M; Yeddula K; Ganguli S; Blaszkowsky LS; Zhu AX
J Vasc Interv Radiol; 2013 Feb; 24(2):257-65. PubMed ID: 23369560
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
